Estee Lauder Delivered Positive FQ4 Revenue and Margin Performance and Further Raised FY27 Operating Margin Guidance

Overview

The report positively assesses Estee Lauder's FQ4 results: revenue growth met or exceeded expectations, while gross margin improvement drove meaningful operating margin expansion, offsetting a higher selling, general and administrative expense ratio. Management maintained its FY27 organic sales growth outlook while raising operating margin guidance; accordingly, J.P. Morgan remains constructive on the company's growth and earnings recovery.

Core views

FQ4 earnings performance needs to be assessed by separating one-time items from operating impacts. Estee Lauder reported adjusted EPS of US$0.39, an increase of more than 100% year over year, albeit against a low comparison base. This included a one-time tariff refund of US$0.07; excluding it, EPS was US$0.32. The Middle East conflict had an additional negative impact of US$0.05; excluding that impact as well, normalized EPS would have been approximately US$0.37. Because prior guidance had already incorporated the impact of the Middle East conflict, the report considers US$0.32 excluding the tariff refund to be a more appropriate comparable measure. This figure was slightly below J.P. Morgan's expectation but in line with market consensus of US$0.32. On the reported basis, disclosed EPS of US$0.39 was US$0.05 and US$0.07 above J.P. Morgan's and the market's forecasts, respectively, and was also above the previously implied range of US$0.23 to US$0.33. The earnings beat was primarily driven by gross margin rather than expense control. FQ4 gross margin reached 75.5%, including the impact of the tariff refund, increasing approximately 365 basis points year over year and coming in approximately 270 basis points above J.P. Morgan's forecast; in EPS contribution terms, this represented an approximately US$0.19 positive variance versus forecast. Meanwhile, the selling, general and administrative expense ratio was 68.2%, nearly 190 basis points above J.P. Morgan's forecast and up 35 basis points year over year, representing an approximately US$0.13 negative contribution to EPS. Non-operating items contributed another approximately US$0.01 negative impact. Overall, adjusted operating margin reached 7.3%, expanding approximately 330 basis points year over year and exceeding J.P. Morgan's forecast by more than 80 basis points. The report attributes this improvement to higher gross margin and the continued implementation of PRGP and Beauty Reimagined initiatives. Revenue growth broadened across regions and categories. Companywide FQ4 organic sales grew 5.0%, including a 1 percentage point drag from the Middle East conflict. This growth rate was broadly in line with J.P. Morgan's 4.9%, above the Consensus Metrix forecast of approximately 3.5%, and above implied guidance of approximately 3%. All four regions grew: Asia-Pacific increased 9.0%, slightly below J.P. Morgan's 10%; Mainland China increased 7.0%, in line with forecast; the Americas increased 5.0%, significantly better than the 0% forecast; and EUKEM increased 1.0%, below the 3.0% forecast. Three of the four categories grew: fragrance increased 10.0%; skin care, an important and higher-margin business, increased 7.0%; makeup increased 2.0%; and hair care declined 1.0%. This indicates that growth is no longer confined to a single market or category, although hair care and EUKEM remain relatively weak. FY27 revenue guidance maintained the previous framework. Management provided organic sales growth guidance of 3% to 5%, consistent with the preliminary outlook and broadly encompassing J.P. Morgan's pre-announcement forecast of 4.1% and the market forecast of 3.8%. Growth is expected to be stronger in the first half, reflecting more product launches earlier in FY27, increased shipments driven by improving travel retail trends, and an easier comparison against lower travel retail shipments in the first half of FY26. By category, fragrance and skin care are expected to maintain momentum, while makeup is expected to return to growth over the full fiscal year. Regional growth is expected to become more diversified; EUKEM will benefit in the second half from a low comparison base caused by the Middle East conflict, and management does not expect the conflict to have a material impact on FY27. Margin guidance is the positive change emphasized most by the report. Management expects modest gross margin expansion and continued operating leverage from non-consumer-facing expenses, and therefore set FY27 adjusted operating margin guidance at 12.7% to 13.5%; the midpoint is 35 basis points above the previous preliminary outlook of 12.5% to 13.0%. Before the announcement, J.P. Morgan and the market forecast operating margins of 13.2% and 12.9%, respectively. FY27 adjusted EPS guidance was US$3.10 to US$3.35, representing year-over-year growth of 24% to 34%; the midpoint was approximately US$0.05 and US$0.04 above J.P. Morgan's and the market's prior expectations, respectively. Other guidance included an effective tax rate of approximately 33% to 34%, net cash flow from operating activities of US$1.3 billion to US$1.4 billion, and capital expenditures of approximately 4% of sales. J.P. Morgan believes the initial guidance may still be conservative, leaving room for further upside. The report notes that Estee Lauder shares rose 6.4% over the past three months, while the consumer staples ETF XLP declined 0.1% over the same period. Nevertheless, with revenue momentum continuing, substantially all PRGP actions expected to be completed in FY27, and most steady-state benefits still to be realized in FY27, the shares may continue to outperform. This view also depends on further clarification of guidance and operating trends during the earnings call.

Analysis framework

The report first separates reported EPS into the tariff refund, the impact of the Middle East conflict, and continuing operating results to determine a more comparable level of earnings. It then uses gross margin, the selling, general and administrative expense ratio, and non-operating items to explain variances in EPS and operating margin relative to forecasts. Revenue is analyzed by region and category, after which FQ4 trends are linked to FY27 product launches, travel retail, regional comparison bases, expense leverage, and the realization of PRGP benefits, ultimately forming a view on FY27 guidance and the stock's relative performance.

Methodology notes

• Company Fundamentals and Financial FrameworkEarnings Quality Analysis

  EPS Adjusted for One-Time Items and Conflict Impacts

  The report separately excludes the US$0.07 tariff refund and identifies the US$0.05 drag from the Middle East conflict to distinguish reported earnings, comparable earnings, and normalized operating performance.

• Company Fundamentals and Financial FrameworkOperating/Financial Leverage Analysis

  Bridge Across Gross Margin, Expense Ratio, and Operating Margin

  The report compares changes in gross margin and the selling, general and administrative expense ratio against forecasts and the prior-year period to explain operating margin expansion and the increase in FY27 margin guidance.

• Event-Driven Strategy and Behavioral FinanceExpectation Gap/Expectation Management

  Comparison of Actual Results and Management Guidance Against Institutional and Market Forecasts

  The report compares FQ4 sales, EPS, and margins, as well as FY27 guidance, item by item against forecasts from J.P. Morgan, Consensus Metrix, and Bloomberg, and uses these comparisons to assess the magnitude of the earnings beat and whether the initial guidance is conservative.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• The Estee Lauder Cos (EL.US)

  The report believes the company is benefiting from broader global revenue growth, gross margin improvement, progress on PRGP and Beauty Reimagined initiatives, and higher FY27 operating margin guidance.

  Strengths

  All four regions achieved organic growth; fragrance and skin care delivered strong growth; gross margin and operating margin improved significantly; FY27 margin and EPS guidance exceeded prior expectations.

  Weaknesses

  The selling, general and administrative expense ratio was above J.P. Morgan's forecast, hair care sales declined 1%, and EUKEM growth was below forecast.

  Comparison

  The share price rose 6.4% over the past three months, while XLP declined 0.1% over the same period; FQ4 organic sales growth exceeded the market forecast, and operating margin was also more than 80 basis points above J.P. Morgan's forecast.

  Risks

  The Middle East conflict reduced FQ4 organic sales growth by approximately 1 percentage point and EPS by approximately US$0.05; its subsequent impact still needs to be monitored in conjunction with further company commentary.

Key data

• FQ4 Adjusted EPSUS$0.39Increased more than 100% year over year and included a one-time tariff refund of US$0.07
• FQ4 EPS Excluding Tariff RefundUS$0.32In line with market consensus; the quarter also incurred a US$0.05 drag from the Middle East conflict
• FQ4 Organic Sales Growth5.0%Included a 1 percentage point drag from the Middle East conflict; J.P. Morgan forecast 4.9%
• FQ4 Gross Margin75.5%Increased approximately 365 basis points year over year and was approximately 270 basis points above J.P. Morgan's forecast
• FQ4 Selling, General and Administrative Expense Ratio68.2%Nearly 190 basis points above J.P. Morgan's forecast and up 35 basis points year over year
• FQ4 Adjusted Operating Margin7.3%Increased approximately 330 basis points year over year and was more than 80 basis points above J.P. Morgan's forecast
• FQ4 Regional Organic GrowthAsia-Pacific 9.0%, Mainland China 7.0%, Americas 5.0%, EUKEM 1.0%All four regions achieved growth
• FQ4 Category Organic GrowthFragrance 10.0%, Skin Care 7.0%, Makeup 2.0%, Hair Care -1.0%Three of the four categories grew
• FY27 Organic Sales Growth Guidance3%-5%Maintained the previous preliminary outlook
• FY27 Adjusted Operating Margin Guidance12.7%-13.5%The midpoint was raised by 35 basis points from the preliminary outlook of 12.5%-13.0%
• FY27 Adjusted EPS GuidanceUS$3.10-US$3.35Representing year-over-year growth of 24%-34%
• FY27 Effective Tax Rate GuidanceApproximately 33%-34%Management's initial guidance
• FY27 Net Cash Flow from Operating Activities GuidanceUS$1.3 billion-US$1.4 billionManagement's initial guidance
• FY27 Capital Expenditure GuidanceApproximately 4% of salesManagement's initial guidance

Impact & implications

The report believes that FQ4 gross margin improvement, renewed growth across all regions, and the increase in FY27 operating margin guidance demonstrate that Estee Lauder's revenue and earnings recovery is progressing. If product launches, travel retail improvement, expense leverage, and PRGP steady-state benefits materialize as planned, management's current FY27 guidance may still have upside and could support continued relative strength in the shares.

Risks

• The Middle East conflict caused an approximately 1 percentage point drag on FQ4 organic sales growth and an approximately US$0.05 negative impact on EPS, although management does not expect a material impact on FY27.

What to watch

• Watch for further commentary during the earnings call regarding FY27 guidance, operating trends, and potential upside.
• Watch whether product launches and improved travel retail shipments in the first half of FY27 can drive stronger growth.
• Watch whether fragrance and skin care can maintain momentum and whether makeup can return to growth for the full FY27.
• Watch whether PRGP actions can be substantially completed in FY27 and whether most steady-state benefits can be realized as scheduled.
• Watch whether modest gross margin expansion and leverage from non-consumer-facing expenses can support operating margin guidance of 12.7% to 13.5%.